Plasma and Intracellular Pharmacokinetics of Darunavir/Ritonavir Once Daily and Raltegravir Once and Twice Daily in HIV-Infected Individuals

Journal of Acquired Immune Deficiency Syndromes- United States

doi 10.1097/qai.0b013e3182364c67

Full Text

Abstract

Available in

Date

Authors

Publisher

Ovid Technologies (Wolters Kluwer Health)


Related search